Lin Q - Search Results

1

Depletion of circ_0007841 inhibits multiple myeloma development and BTZ resistance via miR-129-5p/JAG1 axis.

Wang Y, Lin Q, Song C, Ma R, Li X. Wang Y, et al. Among authors: lin q. Cell Cycle. 2020 Dec;19(23):3289-3302. doi: 10.1080/15384101.2020.1839701. Epub 2020 Nov 1. Cell Cycle. 2020. PMID: 33131409 Free PMC article.

2

The Biological Function and Clinical Significance of miR-886-5p in Multiple Myeloma.

Xiang P, Liu Y, Liu L, Lin Q, Liu X, Zhang H, Xu J, Fang B. Xiang P, et al. Among authors: lin q. Acta Haematol. 2019;142(4):208-216. doi: 10.1159/000499620. Epub 2019 Jun 4. Acta Haematol. 2019. PMID: 31163428

3

Circ_0007841 promotes the progression of multiple myeloma through targeting miR-338-3p/BRD4 signaling cascade.

Wang Y, Lin Q, Song C, Ma R, Li X. Wang Y, et al. Among authors: lin q. Cancer Cell Int. 2020 Aug 8;20:383. doi: 10.1186/s12935-020-01475-6. eCollection 2020. Cancer Cell Int. 2020. PMID: 32782441 Free PMC article.

4

[PX-12 Promoting Apoptosis of Multiple Myeloma Cell Line H929 Induced by Bortezomib].

Lin QD, Yan Y, Liu Q, DU JW, Gao X, Zuo WL, Fang BJ, Li YF, Wei XD, Song YP. Lin QD, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Apr;29(2):515-519. doi: 10.19746/j.cnki.issn.1009-2137.2021.02.032. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021. PMID: 33812423 Chinese.

5

Hsa_circ_0111738 Inhibits Tumor Progression and Angiogenesis in Multiple Myeloma by Sponging miR-1233-3p to Regulate HIF-1 Signaling Pathway.

Wang P, Zhang Y, Lin Q, Zhou J, Lv X, Song Y. Wang P, et al. Among authors: lin q. Arch Med Res. 2023 Jun;54(4):299-309. doi: 10.1016/j.arcmed.2023.05.002. Epub 2023 May 20. Arch Med Res. 2023. PMID: 37211508

6

Bortezomib combined with lenalidomide as the first-line treatment for the rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma: A case report.

Zuo W, Zhu X, Yang J, Mei Z, Deng M, Lin Q, Song Y, Yin Q. Zuo W, et al. Among authors: lin q. Medicine (Baltimore). 2017 Jan;96(1):e5787. doi: 10.1097/MD.0000000000005787. Medicine (Baltimore). 2017. PMID: 28072730 Free PMC article.

7

Clinical observation of recombinant human endostatin in treating relapsed refractory multiple myeloma.

Huang H, Liu Y, Lin QD, Liu YZ, Liu LN, Zhang QL, Yu FK, Song YP, Fang BJ. Huang H, et al. Clin Exp Pharmacol Physiol. 2018 Dec;45(12):1325-1327. doi: 10.1111/1440-1681.13016. Clin Exp Pharmacol Physiol. 2018. PMID: 30075047

8

Retrospective analysis of the efficacy and influencing factors of autologous hematopoietic stem cell transplantation for multiple myeloma.

Zhang BL, Zhou J, Lin QD, Liu YZ, Zhang YL, Gui RR, Song YP, Fang BJ. Zhang BL, et al. Artif Organs. 2019 Oct;43(10):1028-1034. doi: 10.1111/aor.13468. Epub 2019 May 20. Artif Organs. 2019. PMID: 30972806

9

Recent updates on CAR T clinical trials for multiple myeloma.

Lin Q, Zhao J, Song Y, Liu D. Lin Q, et al. Mol Cancer. 2019 Nov 5;18(1):154. doi: 10.1186/s12943-019-1092-1. Mol Cancer. 2019. PMID: 31684964 Free PMC article. Review.

10

LINC00963 facilitates acute myeloid leukemia development by modulating miR-608/MMP-15.

Zuo W, Zhou K, Deng M, Lin Q, Yin Q, Zhang C, Zhou J, Song Y. Zuo W, et al. Among authors: lin q. Aging (Albany NY). 2020 Oct 4;12(19):18970-18981. doi: 10.18632/aging.103252. Epub 2020 Oct 4. Aging (Albany NY). 2020. PMID: 33012724 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,323 results

Search Page

Filters